神経可塑性の世界市場レポート (2025年)

神経可塑性の市場規模は、今後数年間で飛躍的な成長が見込まれます。2029年には年間平均成長率（CAGR）23.2％で151億8,000万米ドルに成長します。予測期間の成長は、ニューロテクノロジーにおける人工知能の統合の増加、個別化された神経治療に対する需要の高まり、ニューロリハビリテーションにおけるバーチャルリアリティの利用拡大、ウェアラブル脳モニタリングデバイスの採用拡大、認知機能強化に焦点を当てた新興企業への投資の増加などに起因すると考えられます。この期間に予想される主な動向には、ブレイン・コンピュータ・インターフェイス技術の進歩、認知トレーニングのためのニューロフィードバック技術の進歩、家庭用神経治療装置の開発、非侵襲的脳刺激法の革新、個別化脳モデリングのためのデジタルツインの出現などがあります。

神経疾患の負担増は、高度な脳治療に対する需要の高まりにより、神経可塑性市場の拡大を牽引しています。神経疾患の発生が増加していることが、今後の市場成長を促進すると予測されています。脳、脊髄、神経系に影響を及ぼすこれらの疾患は、さまざまな身体的、認知的、行動的障害をもたらします。アルツハイマー病、パーキンソン病、てんかん、多発性硬化症などの疾患は、人口の高齢化や生活習慣に関連する要因が主な原因となって、より広まりつつあります。世界の平均寿命の伸びに伴い、加齢に伴う神経疾患の開発リスクは上昇し、世界中で罹患率の上昇に寄与しています。こうした疾患の蔓延は、脳機能と患者の予後を改善する革新的な治療法やリハビリテーション技術に対する需要を高めています。この動向は、神経可塑性に基づく治療の進歩を支えています。例えば、2023年10月、英国を拠点とする各国の神経学会の組織である世界神経学連合（World Federation of Neurology）は、現在世界人口の40％以上が何らかの神経疾患に罹患しており、この数字は2050年までにほぼ倍増すると予測されていると報告しました。その結果、神経疾患の有病率の上昇が神経可塑性市場の成長に大きく寄与しています。

新興国の神経可塑性市場は、競争力を維持するために、ブレイン・コンピュータ・インターフェイス（BCI）や神経インプラントなどの高度な技術の開発にますます注力しています。これらの高度なニューロテクノロジーは、脳と外部システムとの間に直接的な通信チャネルを作り出します。BCIは通常、脳の信号を使ってコンピューターや人工装具を操作できるようにするもので、神経インプラントは脳や神経系に挿入され、治療や機能改善のために神経活動を監視、刺激、影響するものです。例えば、2024年6月、米国を拠点とするニューロテクノロジー企業であるパラドロミクス社は、FDAのレギュラトリー・アクセラレーター・プログラムに採択され、新たな患者登録を開始しました。このマイルストーンは、同社の高性能ブレイン・コンピュータ・インターフェイスの開発における重要な一歩であり、高度な神経データ・ソリューションを通じて重度の神経障害を持つ人々の治療選択肢に革命をもたらす可能性を秘めた、神経技術における大きな革新を反映したものです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場のマクロ経済シナリオ：金利・インフレ・地政学・貿易戦争・関税・コロナ禍と回復が市場に及ぼす影響を含む

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の神経可塑性市場：PESTEL分析（政治・社会・技術・環境・法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の神経可塑性市場：成長率分析
• 世界の神経可塑性の市場規模・成長率：実績値、2019～2024年
• 世界の神経可塑性の市場規模・成長率：予測値、2024～2029年、2034年
• 世界の神経可塑性市場：総有効市場（TAM）

第6章 市場セグメンテーション

• 世界の神経可塑性市場：製品種類別、実績値・予測値、2019～2024年、2024～2029年、2034年
• ソフトウェアベースのソリューション
• ハードウェアベースのソリューション
• 世界の神経可塑性市場：技術の種類別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 人工知能
• バーチャルリアリティ
• 神経刺激
• ウェアラブルテクノロジー
• 世界の神経可塑性市場：用途別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 脳卒中リハビリテーション
• 外傷性脳損傷（TBI）のリハビリテーション
• 神経変性疾患
• 学習・記憶強化
• 精神疾患
• 世界の神経可塑性市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院・診療所
• 研究機関・学術センター
• 製薬・バイオテクノロジー企業
• その他のエンドユーザー
• 世界の神経可塑性市場：ソフトウェアベース・ソリューションの種類別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 認知トレーニングプログラム
• ニューロフィードバックソフトウェア
• 脳シミュレーションプラットフォーム
• モバイル神経療法アプリ
• VRリハビリソフトウェア
• AIベース認知評価ツール
• 世界の神経可塑性市場：ハードウェアベース・ソリューションの種類別、実績値・予測値、2019～2024年、2024～2029年、2034年
• EEGヘッドセット
• 経頭蓋磁気刺激（TMS）装置
• 経頭蓋直流電流刺激（tDCS）装置
• 脳コンピュータインターフェース（BCI）システム
• ウェアラブル神経刺激装置
• 神経画像・モニタリング機器

第7章 地域別・国別の分析

• 世界の神経可塑性市場：地域別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 世界の神経可塑性市場：国別、実績値・予測値、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 神経可塑性市場：競合情勢
• 神経可塑性市場：企業プロファイル
  • Abbott Laboratories（概要、製品・サービス、戦略、財務分析）
  • Medtronic PLC（概要、製品・サービス、戦略、財務分析）
  • Otsuka Pharmaceutical（概要、製品・サービス、戦略、財務分析）
  • Boston Scientific Corporation（概要、製品・サービス、戦略、財務分析）
  • Biogen Inc.（概要、製品・サービス、戦略、財務分析）

第31章 その他の大手企業と革新的企業

• Neurocrine Biosciences
• Axsome Therapeutics
• NeuroPace Inc.
• BrainsWay Ltd.
• Magstim
• MindMaze
• Emotiv Inc.
• BrainCo
• ElectroCore
• NeuroMetrix
• Sage Therapeutics
• Soterix Medical
• Neurable
• NeuroSigma Inc.
• Cognixion

第32章 世界市場：競合ベンチマーキング・ダッシュボード

第33章 主要な企業合併・買収 (M&A)

第34章 最近の市場動向

第35章 市場の潜在力の高い国・部門と戦略

• 神経可塑性市場：最新機会を提供する国（2029年）
• 神経可塑性市場：最新機会を提供する部門（2029年）
• 神経可塑性市場：成長戦略（2029年）
  • 市場動向に基づく戦略
  • 競争戦略

第36章 付録

Neuroplasticity refers to the brain's capacity to reorganize and adjust by creating new neural connections throughout an individual's lifetime. This ability allows the brain to respond to new experiences, learning processes, and injuries by either strengthening or weakening synapses. The primary objective of neuroplasticity is to facilitate cognitive flexibility, learning, memory retention, and recovery following brain injury. Additionally, it contributes to skill enhancement, boosts mental resilience, aids in rehabilitation, and supports the brain's long-term health and adaptability.

The primary categories of neuroplasticity products consist of software-based and hardware-based solutions. Software-based approaches involve digital tools and programs aimed at enhancing brain performance by activating neural circuits. These include cognitive training applications, virtual reality environments, and brainwave modulation software designed to support learning, memory, and post-injury recovery. Technologies used in this area include artificial intelligence, virtual reality, neurostimulation, and wearable devices. These solutions are applied in areas such as stroke recovery, traumatic brain injury (TBI) treatment, neurodegenerative disease management, cognitive enhancement, and mental health care. They are utilized by hospitals and clinics, academic and research institutions, pharmaceutical and biotech firms, among others.

The neuroplasticity market research report is one of a series of new reports from The Business Research Company that provides neuroplasticity market statistics, including neuroplasticity industry global market size, regional shares, competitors with a neuroplasticity market share, detailed neuroplasticity market segments, market trends and opportunities, and any further data you may need to thrive in the neuroplasticity industry. This neuroplasticity market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The neuroplasticity market size has grown exponentially in recent years. It will grow from $5.34 billion in 2024 to $6.59 billion in 2025 at a compound annual growth rate (CAGR) of 23.4%. Growth during the historic period can be credited to the growing interest in brain-computer interface technologies, expanded funding for neuroscience research, the global rise in mental health issues, increasing clinical validation of therapies based on neuroplasticity, and the heightened adoption of digital therapeutics in cognitive healthcare.

The neuroplasticity market size is expected to see exponential growth in the next few years. It will grow to $15.18 billion in 2029 at a compound annual growth rate (CAGR) of 23.2%. Growth in the forecast period can be attributed to the increasing integration of artificial intelligence in neurotechnology, rising demand for personalized neurotherapies, expanding use of virtual reality in neurorehabilitation, greater adoption of wearable brain-monitoring devices, and growing investments in startups focused on cognitive enhancement. Major trends expected during this period include advancements in brain-computer interface technologies, progress in neurofeedback techniques for cognitive training, the development of home-based neurotherapy devices, innovations in non-invasive brain stimulation methods, and the emergence of digital twins for personalized brain modeling.

The growing burden of neurological disorders is driving the expansion of the neuroplasticity market due to rising demand for advanced brain therapies. The increasing occurrence of neurological conditions is anticipated to fuel market growth moving forward. These disorders, which affect the brain, spinal cord, and nervous system, result in various physical, cognitive, and behavioral impairments. Conditions such as Alzheimer's disease, Parkinson's disease, epilepsy, and multiple sclerosis are becoming more widespread, largely due to aging populations and lifestyle-related factors. As global life expectancy increases, the risk of developing age-related neurological disorders rises, contributing to higher incidence rates across the world. The prevalence of these conditions is generating greater demand for innovative therapies and rehabilitation technologies that improve brain function and patient outcomes. This trend supports the advancement of neuroplasticity-based treatments. For example, in October 2023, the World Federation of Neurology, a UK-based organization of national neurological societies, reported that over 40% of the global population is currently affected by some form of neurological condition, and this figure is projected to nearly double by 2050. As a result, the rising prevalence of neurological disorders is significantly contributing to the growth of the neuroplasticity market.

Key players in the neuroplasticity market are increasingly focused on developing sophisticated technologies such as brain-computer interfaces (BCIs) and neural implants to maintain their competitive edge. These advanced neurotechnologies create direct communication channels between the brain and external systems. BCIs typically allow users to control computers or prosthetic devices using brain signals, while neural implants are inserted into the brain or nervous system to monitor, stimulate, or influence neural activity for therapeutic or functional improvement. For example, in June 2024, Paradromics, a U.S.-based neurotechnology firm, was accepted into the FDA Regulatory Accelerator Program and launched a new patient registry. This milestone represents a significant step in the development of the company's high-performance brain-computer interfaces, reflecting major innovation in neurotechnology that holds potential to revolutionize treatment options for individuals with severe neurological disorders through advanced neural data solutions.

In April 2022, Blackrock Neurotech, a brain-computer interface company based in the U.S., acquired MindX for an undisclosed amount. This acquisition reinforces Blackrock's end-to-end BCI platform by enhancing its capabilities in developing commercial-grade brain-computer interface technologies. The integration of MindX's spatial computing software is expected to accelerate the development and commercialization of next-generation neural interface systems designed for medical use. MindX, also based in the U.S., specializes in creating spatial computing software for augmented reality and neural interface applications.

Major players in the neuroplasticity market are Abbott Laboratories, Medtronic PLC, Otsuka Pharmaceutical, Boston Scientific Corporation, Biogen Inc., Neurocrine Biosciences, Axsome Therapeutics, NeuroPace Inc., BrainsWay Ltd., Magstim, MindMaze, Emotiv Inc., BrainCo, ElectroCore, NeuroMetrix, Sage Therapeutics, Soterix Medical, Neurable, NeuroSigma Inc., Cognixion, and NeuroTracker.

North America was the largest region in the Neuroplasticity market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in neuroplasticity report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the neuroplasticity market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The neuroplasticity market consists of revenues earned by entities by providing services such as cognitive rehabilitation, brain training solutions, neurostimulation therapies, and neurological recovery programs that enhance or restore the brain's adaptive capacity across various neurological and psychiatric conditions. The market value includes the value of related goods sold by the service provider or included within the service offering. The neuroplasticity market also includes sales of electroencephalogram (EEG), transcranial direct current stimulation (tDCS) devices, and meditation biofeedback sensors. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neuroplasticity Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neuroplasticity market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neuroplasticity ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The neuroplasticity market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Software-Based Solutions; Hardware-Based Solutions
• 2) By Technology Type: Artificial Intelligence; Virtual Reality; Neurostimulation; Wearable Technology
• 3) By Application: Stroke Rehabilitation; Traumatic Brain Injury (TBI) Rehabilitation; Neurodegenerative Disorders; Learning And Memory Enhancement; Mental Health Disorders
• 4) By End User: Hospitals And Clinics; Research Institutes And Academic Centers; Pharmaceutical And Biotechnology Companies; Other End Users
• Subsegment:
• 1) By Software-Based Solutions: Cognitive Training Programs, Neurofeedback Software, Brain Simulation Platforms, Mobile Neurotherapy Apps, Virtual Reality Rehabilitation Software, AI-Based Cognitive Assessment Tools
• 2) By Hardware-Based Solutions: EEG Headsets, Transcranial Magnetic Stimulation (TMS) Devices, Transcranial Direct Current Stimulation (tDCS) Devices, Brain-Computer Interface (BCI) Systems, Wearable Neurostimulation Devices, Neuroimaging And Monitoring Equipment
• Companies Mentioned: Abbott Laboratories; Medtronic PLC; Otsuka Pharmaceutical; Boston Scientific Corporation; Biogen Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Neuroplasticity Market Characteristics

3. Neuroplasticity Market Trends And Strategies

4. Neuroplasticity Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Neuroplasticity Growth Analysis And Strategic Analysis Framework

• 5.1. Global Neuroplasticity PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Neuroplasticity Market Growth Rate Analysis
• 5.4. Global Neuroplasticity Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Neuroplasticity Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Neuroplasticity Total Addressable Market (TAM)

6. Neuroplasticity Market Segmentation

• 6.1. Global Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Software-Based Solutions
• Hardware-Based Solutions
• 6.2. Global Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Artificial Intelligence
• Virtual Reality
• Neurostimulation
• Wearable Technology
• 6.3. Global Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Stroke Rehabilitation
• Traumatic Brain Injury (TBI) Rehabilitation
• Neurodegenerative Disorders
• Learning and Memory Enhancement
• Mental Health Disorders
• 6.4. Global Neuroplasticity Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Research Institutes And Academic Centers
• Pharmaceutical And Biotechnology Companies
• Other End Users
• 6.5. Global Neuroplasticity Market, Sub-Segmentation Of Software-Based Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cognitive Training Programs
• Neurofeedback Software
• Brain Simulation Platforms
• Mobile Neurotherapy Apps
• Virtual Reality Rehabilitation Software
• AI-Based Cognitive Assessment Tools
• 6.6. Global Neuroplasticity Market, Sub-Segmentation Of Hardware-Based Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• EEG Headsets
• Transcranial Magnetic Stimulation (TMS) Devices
• Transcranial Direct Current Stimulation (tDCS) Devices
• Brain-Computer Interface (BCI) Systems
• Wearable Neurostimulation Devices
• Neuroimaging And Monitoring Equipment

7. Neuroplasticity Market Regional And Country Analysis

• 7.1. Global Neuroplasticity Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Neuroplasticity Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Neuroplasticity Market

• 8.1. Asia-Pacific Neuroplasticity Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Neuroplasticity Market

• 9.1. China Neuroplasticity Market Overview
• 9.2. China Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Neuroplasticity Market

• 10.1. India Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Neuroplasticity Market

• 11.1. Japan Neuroplasticity Market Overview
• 11.2. Japan Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Neuroplasticity Market

• 12.1. Australia Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Neuroplasticity Market

• 13.1. Indonesia Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Neuroplasticity Market

• 14.1. South Korea Neuroplasticity Market Overview
• 14.2. South Korea Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Neuroplasticity Market

• 15.1. Western Europe Neuroplasticity Market Overview
• 15.2. Western Europe Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Neuroplasticity Market

• 16.1. UK Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Neuroplasticity Market

• 17.1. Germany Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Neuroplasticity Market

• 18.1. France Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Neuroplasticity Market

• 19.1. Italy Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Neuroplasticity Market

• 20.1. Spain Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Neuroplasticity Market

• 21.1. Eastern Europe Neuroplasticity Market Overview
• 21.2. Eastern Europe Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Neuroplasticity Market

• 22.1. Russia Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Neuroplasticity Market

• 23.1. North America Neuroplasticity Market Overview
• 23.2. North America Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Neuroplasticity Market

• 24.1. USA Neuroplasticity Market Overview
• 24.2. USA Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Neuroplasticity Market

• 25.1. Canada Neuroplasticity Market Overview
• 25.2. Canada Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Neuroplasticity Market

• 26.1. South America Neuroplasticity Market Overview
• 26.2. South America Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Neuroplasticity Market

• 27.1. Brazil Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Neuroplasticity Market

• 28.1. Middle East Neuroplasticity Market Overview
• 28.2. Middle East Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Neuroplasticity Market

• 29.1. Africa Neuroplasticity Market Overview
• 29.2. Africa Neuroplasticity Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Neuroplasticity Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Neuroplasticity Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Neuroplasticity Market Competitive Landscape And Company Profiles

• 30.1. Neuroplasticity Market Competitive Landscape
• 30.2. Neuroplasticity Market Company Profiles
  • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Otsuka Pharmaceutical Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Biogen Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Neuroplasticity Market Other Major And Innovative Companies

• 31.1. Neurocrine Biosciences
• 31.2. Axsome Therapeutics
• 31.3. NeuroPace Inc.
• 31.4. BrainsWay Ltd.
• 31.5. Magstim
• 31.6. MindMaze
• 31.7. Emotiv Inc.
• 31.8. BrainCo
• 31.9. ElectroCore
• 31.10. NeuroMetrix
• 31.11. Sage Therapeutics
• 31.12. Soterix Medical
• 31.13. Neurable
• 31.14. NeuroSigma Inc.
• 31.15. Cognixion

32. Global Neuroplasticity Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Neuroplasticity Market

34. Recent Developments In The Neuroplasticity Market

35. Neuroplasticity Market High Potential Countries, Segments and Strategies

• 35.1 Neuroplasticity Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Neuroplasticity Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Neuroplasticity Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer